Further to its letters dated 18.05.2022 & 30.05.2022, Vivimed Labs has informed that the Board of Directors of the Company at its meeting held on Friday, 3rd June, 2022 has approved the Audited Financial Results for the quarter and year ended 31 March, 2022. In terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, the company enclosed the following: Statement of Audited Standalone Financial Results for the quarter and year ended 31 March, 2022 and Auditors' Report thereon, Statement of Audited Consolidated Financial Results for the quarter and year ended 31 March, 2022 and Auditors' Report thereon and Declaration regarding Audit Reports with unmodified opinion.
The above information is a part of company’s filings submitted to BSE.
